Respiratory failure & ventilation

Effects of non-invasive respiratory support in post-operative patients: a systematic review and network meta-analysis

Crit CarePublished Systematic review and network meta-analysis of randomised and non-randomised controlled trials

Pooled result · Re-intubation rateResult — go to the resultOdds ratio 0.49 95% CI 0.28–0.87

Authors' conclusion

In post-operative patients receiving NRS after extubation, NIV reduced the rate of re-intubation, compared to COT, when used for treatment of post-extubation respiratory failure and in patients at high risk of post-extubation respiratory failure.

Study context

Population
Adults extubated after surgery
Participants
11,292 adults · 33 studies
Comparison
NRS modalities vs conventional oxygen therapy (COT) after extubation
Outcome
Re-intubation rate
Methodological detailsSearch of Medline, Embase, Scopus, Cochrane CENTRAL and Web of Science from inception until February 2, 2024
  • Search of Medline, Embase, Scopus, Cochrane CENTRAL and Web of Science from inception until February 2, 2024

Pooled result

As reported in the abstract

Odds ratio

0.49

95% CI 0.28–0.87

P = 0.015

NIV vs COT
OR 0.49 (95% CI 0.28–0.87); P = 0.015

Further pooled results

Re-intubation rate by indication and risk (subgroup)

Non-invasive ventilation (NIV) effect observed for treatment, not prevention, of post-extubation respiratory failure
NIV effect observed in high-risk, not low-risk, patients

Nosocomial pneumonia, intensive care unit (ICU) LOS, ICU, hospital and long-term mortality

NIV reduced nosocomial pneumonia, ICU LOS, and ICU, hospital and long-term mortality

Safety

NIV did not worsen patient discomfort

Original publication

Effects of non-invasive respiratory support in post-operative patients: a systematic review and network meta-analysis. Crit Care. Published 8 May 2024. doi:10.1186/s13054-024-04924-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.